| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |